Zhengye Biotechnology Hol...

NASDAQ: ZYBT · Real-Time Price · USD
4.73
-4.76 (-50.16%)
At close: Aug 21, 2025, 10:14 AM

Zhengye Biotechnology Cash Flow Statement

Financials in CNY. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
13.47M 37.51M 55.74M 46.47M
Depreciation & Amortization
24.16M 23.91M 18.8M 16.01M
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-6M -10.03M 2.56M 1.91M
Other Non-Cash Items
3.47M 6.5M 10.7M 3.4M
Deferred Income Tax
924K 758K -1.09M -358K
Change in Working Capital
-977K -20.49M -66.82M -33.71M
Operating Cash Flow
41.05M 48.18M 17.34M 31.81M
Capital Expenditures
-27.77M -11.6M -27.33M -26.4M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a -1.22M n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-14.08M -3.15M n/a -7.21M
Investing Cash Flow
-27.66M -11.77M -27.33M -26.27M
Debt Repayment
-2.74M 24.97M 34.88M 8M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-16.02M -39.45M -21.43M -11.05M
Other Financial Acitivies
-3.37M -4.5M n/a n/a
Financial Cash Flow
-22.13M -18.98M 13.46M -3.05M
Net Cash Flow
-8.58M 17.44M 3.46M 2.49M
Free Cash Flow
13.27M 36.58M -9.99M 5.41M